CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Single-Cell Transcriptomics Reveals the Heterogeneity of the Immune Landscape of IDH-Wild-Type High-Grade Gliomas.
Single-Cell Transcriptomics Reveals the Heterogeneity of the Immune Landscape of IDH-Wild-Type High-Grade Gliomas.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
异柠檬酸脱氢酶(IDH)野生型(WT)高级别胶质瘤,尤其是胶质母细胞瘤,具有高度侵袭性且肿瘤微环境免疫抑制。尽管已知肿瘤浸润免疫细胞在胶质瘤发生中发挥关键作用,其异质性及细胞间相互作用仍未充分阐明。
本研究构建了IDH-WT高级别胶质瘤患者肿瘤组织及配对外周血单核细胞(PBMC)中免疫细胞的单细胞转录组图谱。分析鉴定出肿瘤中两个肿瘤相关巨噬细胞(TAM)亚群,其促肿瘤特征最为突出,提示它们可能参与胶质瘤进展。
我们还研究了T细胞分化轨迹,并鉴定出芳香烃受体(AHR)是T细胞功能障碍的调节因子,为胶质瘤免疫治疗提供了潜在靶点。我们进一步证实,敲除AHR可减轻嵌合抗原受体(CAR)T细胞耗竭,并在体外和体内提高CAR-T 细胞抗肿瘤疗效。
最后,我们探究了肿瘤微环境和PBMC中由配体-受体相互作用介导的细胞间通信,揭示了肿瘤微环境内独特的细胞相互作用。综上,本研究提供了IDH-WT高级别胶质瘤的全面免疫图谱,并提出胶质瘤免疫治疗的潜在药物靶点。
Isocitrate dehydrogenase (IDH)-wild-type (WT) high-grade gliomas, especially glioblastomas, are highly aggressive and have an immunosuppressive tumor microenvironment. Although tumor-infiltrating immune cells are known to play a critical role in glioma genesis, their heterogeneity and intercellular interactions remain poorly understood. In this study, we constructed a single-cell transcriptome landscape of immune cells from tumor tissue and matching peripheral blood mononuclear cells (PBMC) from IDH-WT high-grade glioma patients.
Our analysis identified two subsets of tumor-associated macrophages (TAM) in tumors with the highest protumorigenesis signatures, highlighting their potential role in glioma progression.
We also investigated the T-cell trajectory and identified the aryl hydrocarbon receptor (AHR) as a regulator of T-cell dysfunction, providing a potential target for glioma immunotherapy.
We further demonstrated that knockout of AHR decreased chimeric antigen receptor (CAR) T-cell exhaustion and improved CAR T-cell antitumor efficacy both in vitro and in vivo.
Finally, we explored intercellular communication mediated by ligand-receptor interactions within the tumor microenvironment and PBMCs and revealed the unique cellular interactions present in the tumor microenvironment. Taken together, our study provides a comprehensive immune landscape of IDH-WT high-grade gliomas and offers potential drug targets for glioma immunotherapy.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。